Douglas J. Totten

Dr. Douglas J. Totten

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 September 2020 in American Journal of Rhinology & Allergy
Verified
Journal Article
Closed access
PDF file
NCNikita Chapurin
Nikita Chapurin
DTDouglas J. Totten
Douglas J. Totten
JMJustin C. Morse
Justin C. Morse
MKMohammad S. Khurram
Mohammad S. Khurram
PLPeter C. Louis
Peter C. Louis
NCNaweed I. Chowdhury
Naweed I. Chowdhury
Background: Sinonasal teratocarcinosarcoma (SNTCS) is a rare malignancy of the anterior skull base with only 127 cases described in the English literature. Given the rarity of this tumor, new cases and analysis of published reports may assist in future management of SNTCS. Objectives: 1) Describe findings from a systematic review of all available literature for malignant SNTCS including the clinical presentation, treatment modalities and outcomes. 2) Present two new cases of this rare anterior skull base tumor. 3) Compare treatment outcomes with respect to recurrence and mortality. Methods: A systematic review of all English literature available in 2 comprehensive databases was conducted by two independent reviewers using PRISMA guidelines. 85 publications were identified. Each case was reviewed for demographics, treatment and survival, and aggregate treatment outcomes were compared using Kaplan-Meier analysis. Results: A total of 64 articles meeting inclusion criteria were reported in the literature between 1977-2018. This represented a total of 127 patients, with a strong male predominance (83%) and mean age of 50 years (range 10–82). Mean follow-up was 21 months. Recurrence rate was 38%, with mean survival at 2 years of 55%. Almost all patients underwent surgery as a primary treatment modality (90%). The majority of cases were treated with multimodal therapy, with 55% receiving surgery and radiation and 20% receiving surgery with adjuvant chemoradiation. Kaplan-Meier analysis demonstrated a significant survival advantage for patients treated with combined therapy compared to surgery alone (p < 0.001) but did not show differences in recurrence (p = 0.085). Conclusion: Two-year survival rates for SNTCS are 55%. Multimodality treatment outcomes appear to be superior to surgery alone based on the published data of this rare skull base tumor, although heterogeneity of treatment methods and reporting bias limits the generalizability of these findings.

12 August 2022 in Journal of Medical Genetics
Verified
Journal Article
Closed access
PDF file
YCYuan-Siao Chen
Yuan-Siao Chen
ECErnesto Cabrera
Ernesto Cabrera
BTBrady J Tucker
Brady J Tucker
TSTimothy J Shin
Timothy J Shin
JMJasmine V Moawad
Jasmine V Moawad
RNRick F. Nelson
Rick F. Nelson
Background: It is well established that biallelic mutations in transmembrane protease, serine 3 (TMPRSS3) cause hearing loss. Currently, there is controversy regarding the audiological outcomes after cochlear implantation (CI) for TMPRSS3-associated hearing loss. This controversy creates confusion among healthcare providers regarding the best treatment options for individuals with TMPRSS3-related hearing loss. Methods: A literature review was performed to identify all published cases of patients with TMPRSS3-associated hearing loss who received a CI. CI outcomes of this cohort were compared with published adult CI cohorts using postoperative consonant-nucleus-consonant (CNC) word performance. TMPRSS3 expression in mouse cochlea and human auditory nerves (HAN) was determined by using hybridisation chain reaction and single-cell RNA-sequencing analysis. Results: In aggregate, 27 patients (30 total CI ears) with TMPRSS3-associated hearing loss treated with CI, and 85% of patients reported favourable outcomes. Postoperative CNC word scores in patients with TMPRSS3-associated hearing loss were not significantly different than those seen in adult CI cohorts (8 studies). Robust Tmprss3 expression occurs throughout the mouse organ of Corti, the spindle and root cells of the lateral wall and faint staining within <5% of the HAN, representing type II spiral ganglion neurons. Adult HAN express negligible levels of TMPRSS3. Conclusion: The clinical features after CI and physiological expression of TMPRSS3 suggest against a major role of TMPRSS3 in auditory neurons.

10 February 2021 in The Laryngoscope
Verified
Journal Article
Closed access
PDF file
DTDouglas J. Totten
Douglas J. Totten
NMNauman F. Manzoor
Nauman F. Manzoor
EPElizabeth L. Perkins
Elizabeth L. Perkins
RLRobert F. Labadie
Robert F. Labadie
MBMarc L. Bennett
Marc L. Bennett
DHDavid S. Haynes
David S. Haynes

22 October 2020 in Ear, Nose & Throat Journal
Verified
Journal Article
Open access
PDF file
NCNikita Chapurin
Nikita Chapurin
DTDouglas J. Totten
Douglas J. Totten
PLPeter C. Louis
Peter C. Louis
JLJr James S. Lewis
Jr James S. Lewis
NCNaweed I. Chowdhury
Naweed I. Chowdhury
RCRakesh K. Chandra
Rakesh K. Chandra
Sinonasal small cell neuroendocrine carcinoma (SNEC) is an extremely rare and aggressive neoplasm that can arise in the sinonasal region. These tumors are associated with high morbidity and mortality, are difficult to diagnose, and are hard to treat. We describe 2 cases of this poorly understood malignancy and review imaging, pathology, and treatment decisions. A 41-year-old male and a 64-year-old female presented to a tertiary center in 2019 after developing nasal obstruction and were found to have sinonasal masses on imaging. Both biopsies showed strong expression of pancytokeratin with dot-like reactivity and expression of neuroendocrine markers chromogranin and synaptophysin. The findings were diagnostic of SNEC. Staging positron emission tomography/computed tomography and brain MRI were performed, and patients were discussed at a multidisciplinary tumor board. Neither had distant metastatic disease at presentation. One patient had no intracranial or orbital disease and underwent a subtotal endoscopic resection with adjuvant chemoradiation. The other patient demonstrated middle cranial fossa, dural, and orbital involvement as well as cranial nerve V palsy. This patient was treated with induction chemotherapy, followed by concurrent chemoradiation. Both patients are presently alive at 4 months follow-up, but one with persistent local disease and the other distant metastasis. Sinonasal small cell neuroendocrine carcinoma is a rare and poorly understood malignancy with an aggressive clinical course. Continued careful review of pathology and study of molecular features are needed for improved understanding of SNEC, and particularly for head and neck SNEC, to establish a staging system and better formulate treatment protocols.

1 July 2021 in American Journal of Otolaryngology
Verified
Journal Article
Closed access
DTDouglas J. Totten
Douglas J. Totten
NMNauman F. Manzoor
Nauman F. Manzoor
EPElizabeth L. Perkins
Elizabeth L. Perkins
NCNathan D. Cass
Nathan D. Cass
MBMarc L. Bennett
Marc L. Bennett
DHDavid S. Haynes
David S. Haynes

12 March 2021 in Journal of Neurological Surgery Part B: Skull Base
Verified
Journal Article
Closed access
PDF file
DTDouglas J. Totten
Douglas J. Totten
NMNauman F. Manzoor
Nauman F. Manzoor
KYKristen L. Yancey
Kristen L. Yancey
RYRobert J. Yawn
Robert J. Yawn
DHDavid S. Haynes
David S. Haynes
ARAlejandro Rivas
Alejandro Rivas
Objective To compare the use of porcine small intestinal submucosal grafts (SISG) and standard autologous material (fascia) in prevention of cerebrospinal fluid (CSF) leak and pseudomeningocele formation after translabyrinthine resection. Setting Set at the tertiary skull base center. Methods This is a retrospective chart review. After Institutional Review Board approval, we performed a retrospective cohort study evaluating CSF leak in patients who underwent resection of lateral skull base defects with multilayered reconstruction using either fascia autograft or porcine SISGs. Demographics were summarized with descriptive statistics. Logistic regression was used to compare autograft and xenograft cohorts in terms of CSF complications. Results Seventy-seven patients underwent lateral skull base resection, followed by reconstruction of the posterior cranial fossa. Of these patients, 21 (27.3%) underwent multilayer repair using SISG xenograft. There were no significant differences in leak-associated complications between autograft and xenograft cohorts. Ventriculoperitoneal shunt was necessary in one (1.8%) autograft and one (4.8) xenograft cases (p = 0.49). Operative repair to revise surgical defect was necessary in three (5.4%) autograft cases and none in xenograft cases. Conclusion The use of SISG as a component of complex skull base reconstruction after translabyrinthine tumor resection may help reduce CSF leak rates and need for further intervention.